Memorial Sloan Kettering and Cornell University to launch nanomedicine center

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

MEMORIAL SLOAN KETTERING CANCER CENTER and Cornell University are opening a new $10 million Center of Cancer Nanotechnology Excellence. The MSKCC-Cornell Center for Translation of Cancer Nanomedicines is funded with an $8.2 million grant from the NCI Alliance for Nanotechnology in Cancer and more than $1.9 million from MSKCC. The center—which will have one facility...

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe

YOU MAY BE INTERESTED IN

I have spent over 20 years running a tumor imaging metrics core at an academic cancer center. In that time, I have watched clinical trial enrollment concentrate at a relatively small number of flagship academic institutions. Unfortunately, trials do not propagate well to the community sites where most patients prefer to receive care. The explanations usually offered for why this happens have never fully accounted for what I observed.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login